Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Weigel

Showing results (331-340 of 423) with videos related to

Pageof 43
Sort By:
Cancer|April 20, 2023
Pediatric phase 2 trial of a WEE1 inhibitor, adavosertib (AZD1775), and irinotecan for relapsed neuroblastoma, medulloblastoma, and rhabdomyosarcomaKristina A Cole, Heba Ijaz, Lea F Surrey, et al.
Journal of the American College of Surgeons|July 8, 2025
Site Reviewer Perspectives on the Implementation of the Commission on Cancer Operative StandardsAlison S Baskin, Timothy Kravchenko, Elizabeth C Funk, et al.
British Journal of Haematology|March 16, 2017
A phase 1 trial of temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukaemia: a Children's Oncology Group study (ADVL1114)Susan R Rheingold, Sarah K Tasian, James A Whitlock, et al.
Pediatric Blood & Cancer|January 8, 2024
A phase 1 trial utilizing a pharmacokinetic endpoint to determine the optimal dose of ramucirumab in children and adolescents with relapsed or refractory solid tumors, including central nervous system tumorsKristy L Pilbeam, Kamnesh Pradhan, James Croop, et al.
Journal of the American College of Surgeons|August 18, 2020
Perioperative Pain Management after Ambulatory Abdominal Surgery: An American College of Surgeons Systematic ReviewQ Lina Hu, Jill Q Dworsky, Anna C Beck, et al.
Cancer Research|July 2, 2021
AP-2α-Mediated Activation of E2F and EZH2 Drives Melanoma MetastasisJeffrey R White, Dakota T Thompson, Kelsey E Koch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2013
A phase I trial of imetelstat in children with refractory or recurrent solid tumors: a Children's Oncology Group Phase I Consortium Study (ADVL1112)Patrick A Thompson, Rachid Drissi, Jodi A Muscal, et al.
Plos One|July 14, 2012
Rapid vascular responses to anthrax lethal toxin in mice containing a segment of chromosome 11 from the CAST/Ei strain on a C57BL/6 genetic backgroundKelsey J Weigel, Laura Rues, Edward J Doyle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2026
National Quality Improvement Initiative to Increase Smoking Cessation Assistance in Commission on Cancer Programs and National Accreditation Program for Breast CentersTracey Pu, Jessica L Burris, Richard S Matulewicz, et al.
European Journal of Cancer (Oxford, England : 1990)|August 3, 2024
Phase 1 study of NEDD8 activating enzyme inhibitor pevonedistat in combination with chemotherapy in pediatric patients with recurrent or refractory solid tumors (ADVL1615)Jennifer H Foster, Joel M Reid, Charles Minard, et al.
Pageof 43

Showing results (331-340 of 423) with videos related to

Sort By:
Pageof 43
Cancer|April 20, 2023
Pediatric phase 2 trial of a WEE1 inhibitor, adavosertib (AZD1775), and irinotecan for relapsed neuroblastoma, medulloblastoma, and rhabdomyosarcomaKristina A Cole, Heba Ijaz, Lea F Surrey, et al.
Journal of the American College of Surgeons|July 8, 2025
Site Reviewer Perspectives on the Implementation of the Commission on Cancer Operative StandardsAlison S Baskin, Timothy Kravchenko, Elizabeth C Funk, et al.
British Journal of Haematology|March 16, 2017
A phase 1 trial of temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukaemia: a Children's Oncology Group study (ADVL1114)Susan R Rheingold, Sarah K Tasian, James A Whitlock, et al.
Pediatric Blood & Cancer|January 8, 2024
A phase 1 trial utilizing a pharmacokinetic endpoint to determine the optimal dose of ramucirumab in children and adolescents with relapsed or refractory solid tumors, including central nervous system tumorsKristy L Pilbeam, Kamnesh Pradhan, James Croop, et al.
Journal of the American College of Surgeons|August 18, 2020
Perioperative Pain Management after Ambulatory Abdominal Surgery: An American College of Surgeons Systematic ReviewQ Lina Hu, Jill Q Dworsky, Anna C Beck, et al.
Cancer Research|July 2, 2021
AP-2α-Mediated Activation of E2F and EZH2 Drives Melanoma MetastasisJeffrey R White, Dakota T Thompson, Kelsey E Koch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2013
A phase I trial of imetelstat in children with refractory or recurrent solid tumors: a Children's Oncology Group Phase I Consortium Study (ADVL1112)Patrick A Thompson, Rachid Drissi, Jodi A Muscal, et al.
Plos One|July 14, 2012
Rapid vascular responses to anthrax lethal toxin in mice containing a segment of chromosome 11 from the CAST/Ei strain on a C57BL/6 genetic backgroundKelsey J Weigel, Laura Rues, Edward J Doyle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2026
National Quality Improvement Initiative to Increase Smoking Cessation Assistance in Commission on Cancer Programs and National Accreditation Program for Breast CentersTracey Pu, Jessica L Burris, Richard S Matulewicz, et al.
European Journal of Cancer (Oxford, England : 1990)|August 3, 2024
Phase 1 study of NEDD8 activating enzyme inhibitor pevonedistat in combination with chemotherapy in pediatric patients with recurrent or refractory solid tumors (ADVL1615)Jennifer H Foster, Joel M Reid, Charles Minard, et al.
Pageof 43